CARsgen Reports 4.5-Year Follow-Up Data for Satri-cel in Advanced Gastric Cancer at ASCO 2026
SHANGHAI, China, June 1, 2026 CARsgen Therapeutics presented promising long-term follow-up data from its investigational Claudin18.2-targeted CAR T-cell therapy,...
